Preliminary Evidence of Rapid HBsAg Seroconversion in Patients with Chronic Hepatitis B (CHB) Treated with a DNA-based Amphipathic Polymer

MLA

Andrew Vaillant, et al. “Preliminary Evidence of Rapid HBsAg Seroconversion in Patients with Chronic Hepatitis B (CHB) Treated with a DNA-Based Amphipathic Polymer.” Antiviral Research, vol. 86, Apr. 2010, p. A28. EBSCOhost, https://doi.org/10.1016/j.antiviral.2010.02.358.

APA

Andrew Vaillant, Mamun Al-Mahtab, & Michel Bazinet. (2010). Preliminary Evidence of Rapid HBsAg Seroconversion in Patients with Chronic Hepatitis B (CHB) Treated with a DNA-based Amphipathic Polymer. Antiviral Research, 86, A28. https://doi.org/10.1016/j.antiviral.2010.02.358

Chicago

Andrew Vaillant, Mamun Al-Mahtab, and Michel Bazinet. 2010. “Preliminary Evidence of Rapid HBsAg Seroconversion in Patients with Chronic Hepatitis B (CHB) Treated with a DNA-Based Amphipathic Polymer.” Antiviral Research 86 (April): A28. doi:10.1016/j.antiviral.2010.02.358.